Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Santaolalla, Aida"'
Autor:
Beckmann K; Translational Oncology and Urology Research, King's College London, London, UK.; Cancer Epidemiology and Population Health University of South Australia, Adelaide, Australia., Santaolalla A; Translational Oncology and Urology Research, King's College London, London, UK.; Guy's and St Thomas' NHS Foundation Trust, London, UK., Helleman J; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands., Carroll P; Department of Urology, UCSF - Helen Diller Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Ha Chung B; Department of Urology, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, Korea., Shiong Lee L; Department of Urology, Sengkang General Hospital and Singapore General Hospital, Singapore., Perry A; University College Dublin, Dublin, Ireland., Rubio-Briones J; Instituto Valenciano de Oncología, Valencia, Spain., Sugimoto M; Faculty of Medicine, Kagawa University, Kagawa, Japan., Trock B; Johns Hopkins University, The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Valdagni R; Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Milan, Italy.; Radiation Oncology and Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dasgupta P; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Immunology and Microbial Sciences, King's College London, London, UK., Van Hemelrijck M; Translational Oncology and Urology Research, King's College London, London, UK.; Guy's and St Thomas' NHS Foundation Trust, London, UK., Elhage O; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Immunology and Microbial Sciences, King's College London, London, UK.
Publikováno v:
European urology open science [Eur Urol Open Sci] 2021 Nov 01; Vol. 34, pp. 47-54. Date of Electronic Publication: 2021 Nov 01 (Print Publication: 2021).
Autor:
Marsden T; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: teresa.marsden@ucl.ac.uk., McCartan N; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Hadley J; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Tuck S; ReIMAGINE Consortium Patient Representative., Brown L; MRC Clinical Trials Unit, University College London, London, UK., Haire AJ; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Moss CL; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Green S; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Van Hemelrijck M; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Coolen T; London Institute for Mathematical Sciences, London, UK., Santaolalla A; Cancer Epidemiology Group, Division of Cancer Studies, King's College London School of Medicine, London, UK., Isaac E; Centre for Medical Imaging, University College London, London, UK., Brembilla G; Centre for Medical Imaging, University College London, London, UK., Kopcke D; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Giganti F; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Sidhu H; Centre for Medical Imaging, University College London, London, UK., Punwani S; Centre for Medical Imaging, University College London, London, UK., Emberton M; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Moore CM; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
Publikováno v:
European urology focus [Eur Urol Focus] 2021 May; Vol. 7 (3), pp. 503-505. Date of Electronic Publication: 2021 Apr 23.
Autor:
van der Kwast TH; Department of Pathology, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada. Electronic address: theodorus.vanderkwast@uhn.ca., Helleman J; Department of Urology, Erasmus MC, Rotterdam, The Netherlands., Nieboer D; Department of Urology, Erasmus MC, Rotterdam, The Netherlands; Department of Public Health, Erasmus MC, Rotterdam, The Netherlands., Bruinsma SM; Department of Urology, Erasmus MC, Rotterdam, The Netherlands., Roobol MJ; Department of Urology, Erasmus MC, Rotterdam, The Netherlands., Trock B; Johns Hopkins University, The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Ehdaie B; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Carroll P; University of California San Francisco, San Francisco, CA, USA., Filson C; Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, USA., Kim J; MD Anderson Cancer Centre, Houston, TX, USA., Logothetis C; MD Anderson Cancer Centre, Houston, TX, USA., Morgan T; University of Michigan and Michigan Urological Surgery Improvement Collaborative, Michigan, USA., Klotz L; University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Pickles T; University of British Columbia, BC Cancer Agency, Vancouver, Canada., Hyndman E; University of Calgary, Southern Alberta Institute of Urology, Calgary, Canada., Moore CM; University College London and University College London Hospital Trust, London, UK., Gnanapragasam V; University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Van Hemelrijck M; King's College London, London, UK; Guy's and St Thomas' NHS Foundation Trust, London, UK., Dasgupta P; Guy's and St Thomas' NHS Foundation Trust, London, UK., Bangma C; Erasmus Medical Center, Rotterdam, The Netherlands., Roobol M; Erasmus Medical Center, Rotterdam, The Netherlands., Villers A; Lille University Hospital Center, Lille, France., Rannikko A; Helsinki University and Helsinki University Hospital, Helsinki, Finland., Valdagni R; Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Radiation Oncology 1 and Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Perry A; University College Dublin, Dublin, Ireland., Hugosson J; Sahlgrenska University Hospital, Göteborg, Sweden., Rubio-Briones J; Instituto Valenciano de Oncología, Valencia, Spain., Bjartell A; Skåne University Hospital, Malmö, Sweden., Hefermehl L; Kan-tonsspital Baden, Baden, Switzerland., Shiong LL; Singapore General Hospital, Singapore, Singapore., Frydenberg M; Monash Health; Monash University, Melbourne, Australia., Kakehi Y; Kagawa University Faculty of Medicine, Kagawa, Japan., Chung BH; Gangnam Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea., van der Kwast T; Princess Margaret Cancer Centre, Toronto, Canada., Obbink H; Royal Philips, Eindhoven, The Netherlands., van der Linden W; Royal Philips, Eindhoven, The Netherlands., Hulsen T; Royal Philips, Eindhoven, The Netherlands., de Jonge C; Royal Philips, Eindhoven, The Netherlands., Kattan M; Cleveland Clinic, Cleveland, OH, USA., Xinge J; Cleveland Clinic, Cleveland, OH, USA., Muir K; University of Manchester, Manchester, UK., Lophatananon A; University of Manchester, Manchester, UK., Fahey M; Epworth HealthCare, Melbourne, Australia., Steyerberg E; Erasmus Medical Center, Rotterdam, The Netherlands., Nieboer D; Erasmus Medical Center, Rotterdam, The Netherlands., Zhang L; University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Guo W; Johns Hopkins University, The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Benfante N; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cowan J; University of California San Francisco, San Francisco, CA, USA., Patil D; Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, USA., Tolosa E; MD Anderson Cancer Centre, Houston, TX, USA., Kim TK; University of Michigan and Michigan Urological Surgery Improvement Collaborative, Ann Arbor, MI, USA., Mamedov A; University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., LaPointe V; University of British Columbia, BC Cancer Agency, Vancouver, Canada., Crump T; University of Calgary, Southern Alberta Institute of Urology, Calgary, Canada., Kimberly-Duffell J; University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Santaolalla A; King's College London, London, UK., Nieboer D; Erasmus Medical Center, Rotterdam, The Netherlands., Olivier JT; Lille University Hospital Center, Lille, France., Rancati T; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Ahlgren H; Sahlgrenska University Hospital, Göteborg, Sweden., Mascarós J; Instituto Valenciano de Oncología, Valencia, Spain., Löfgren A; Skåne University Hospital, Malmö, Sweden., Lehmann K; Kantonsspital Baden, Baden, Switzerland., Lin CH; Monash University and Epworth HealthCare, Melbourne, Australia., Hirama H; Kagawa University, Kagawa, Japan., Lee KS; Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, Korea., Jenster G; Erasmus MC, Rotterdam, The Netherlands., Auvinen A; University of Tampere, Tampere, Finland., Bjartell A; Instituto Valenciano de Oncología, Valencia, Spain., Haider M; University of Toronto, Toronto, Canada., van Bochove K; The Hyve B.V. Utrecht, Utrecht, The Netherlands., Carter B; Johns Hopkins University, Baltimore, MD, USA., Gledhill S; Movember Foundation, Melbourne, Australia., Buzza M; Movember Foundation, Melbourne, Australia., Bangma C; Erasmus Medical Center, Rotterdam, The Netherlands., Roobol M; Erasmus Medical Center, Rotterdam, The Netherlands., Bruinsma S; Erasmus Medical Center, Rotterdam, The Netherlands., Helleman J; Erasmus Medical Center, Rotterdam, The Netherlands.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2019 May; Vol. 2 (3), pp. 333-336. Date of Electronic Publication: 2018 Sep 13.